Section Arrow
KARD.NASDAQ
- Kardigan Inc
Quotes are at least 15-min delayed:2026/08/07 08:04 EDT
Pre Market
Last
 --
-- (--)
Bid
20.36
Ask
32.57
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 20.36
+0.11 (+0.54%)
Day High 
20.62 
Prev. Close
20.25 
1-M High
24.88 
Volume 
249.17K 
Bid
20.36
Ask
32.57
Day Low
20.03 
Open
20.33 
1-M Low
19.58 
Market Cap 
1.81B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 20.64 
20-SMA 21.63 
50-SMA -- 
52-W High 27 
52-W Low 16.25 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.57/--
Enterprise Value
1.82B
Balance Sheet
Book Value Per Share
-3.37
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ENSCEnsysce Biosciences0.5243+0.1623+44.83%-- 
Pre Market 0.5134 -0.0109 -2.08%
CELZCreative Medical Technology Holdings1.15+0.4812+71.95%-- 
Pre Market 1.35 +0.2 +17.39%
IOVAIovance Biotherapeutics6.21+1.87+43.09%-- 
Pre Market 6.28 +0.07 +1.13%
GERNGeron Corp1.57-0.06-3.68%-- 
Pre Market 1.55 -0.02 -1.27%
RXRXRecursion Pharmaceuticals3.18+0.01+0.32%-- 
Pre Market 3.21 +0.03 +0.94%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a singleoperating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.